Aquestive Therapeutics Inc. (AQST) Tops Q2 EPS by 3c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q2 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $10 million versus the consensus estimate of $11.32 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Alphabet to replace Verizon in the Dow Jones Industrial Average
• Boeing wins $2 billion satellite contract from DoW